Article citationsMore >>

Chang M.S., Minaya M.T., Cheng J., Connor B.A., Lewis S.K., Green P.H., :Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease”, Dig Dis Sci, 2011. 56 (10). 2939-46.

has been cited by the following article:

Article

Should Small Intestine Bacterial Overgrowth be Ruled out as a Cause of Non-Responsive Celiac Disease?: A Case Report

1Gastroenterology Section, Internal Medicine Department. CEMIC, Buenos Aires, Argentina


International Journal of Celiac Disease. 2014, Vol. 2 No. 2, 67-69
DOI: 10.12691/ijcd-2-2-9
Copyright © 2014 Science and Education Publishing

Cite this paper:
Juan Lasa, Ignacio Zubiaurre. Should Small Intestine Bacterial Overgrowth be Ruled out as a Cause of Non-Responsive Celiac Disease?: A Case Report. International Journal of Celiac Disease. 2014; 2(2):67-69. doi: 10.12691/ijcd-2-2-9.

Correspondence to: Juan  Lasa, Gastroenterology Section, Internal Medicine Department. CEMIC, Buenos Aires, Argentina. Email: drjuanslasa@gmail.com

Abstract

Non-responsive celiac disease is defined as the persistency of symptoms, signs or laboratory abnormalities typical of CD despite 6-12 months of dietary gluten avoidance. Small intestine bacterial overgrowth has been classically considered a potential cause for non-responsive celiac disease. Nevertheless, the evidence regarding its prevalence among non-responsive celiac patients is conflicting, as well as the evidence showing a benefit in small intestine bacterial overgrowth treatment in this clinical setting. We report the case of a 34 year-old woman diagnosed with non-responsive celiac disease in spite of adequate gluten-free diet, that had complete resolution of symptoms after treatment with antibiotics for small intestine bacterial overgrowth.

Keywords